Transoral robotic surgery advantages and disadvantages: a narrative review

Voutyrakou, Dialekti Athina; Papanastasis, Athanasios; Chatsikian, Melkon; Katrakazas, Panagiotis; Koutsouris, Dimitrios

doi:10.1049/joe.2017.0409

Cited by 3 publications

(1 citation statement)

References 86 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Notwithstanding the potential advantages of TORS described above, several important complications have also been reported (48), most notably including postoperative bleeding, a potentially life-threatening complication (21). Reported rates of major postoperative hemorrhage are as high as 9.8% (16, 30).…”

Section: Methodsmentioning

confidence: 99%

Functional Organ Preservation Surgery in Head and Neck Cancer: Transoral Robotic Surgery and Beyond

Golusiński

2019

Front. Oncol.

View full text Add to dashboard Cite

In recent years, interest in functional organ preservation surgery (FOPS) in the treatment of head and neck cancer has increased dramatically as clinicians seek to minimize the adverse effects of treatment while maximizing survival and quality of life. In this context, the use of transoral robotic surgery (TORS) is becoming increasingly common. TORS is a relatively new and rapidly-evolving technique, with a growing range of treatment indications. A wide range of novel, flexible surgical robots are now in development and their commercialization is expected to significantly expand the current indications for TORS. In the present review, we discuss the current and future role of this organ-preserving modality as the central element in the multimodal treatment of head and neck cancer.

show abstract

Section: Methodsmentioning

confidence: 99%

Functional Organ Preservation Surgery in Head and Neck Cancer: Transoral Robotic Surgery and Beyond

Golusiński

2019

Front. Oncol.

View full text Add to dashboard Cite

show abstract

Introduction to Robotics in Skull Base Surgery

Al-Salihi,

Al-Jebur,

Al-Salihi

et al. 2023

Robotics in Skull-Base Surgery

View full text Add to dashboard Cite

Current treatments for oropharyngeal squamous cell carcinoma and the move towards molecular therapy

Elmi,

Dass,

Dass

2024

Journal of Pharmacy and Pharmacology

View full text Add to dashboard Cite

Objectives In this review, we discuss oropharyngeal squamous cell carcinoma (OPSCC) treatment options with a focus on the molecular mechanisms of OPSCC in head and neck squamous cell carcinoma (HNSCC) and head and neck cancers (HNCs). Treatment can be radical intent (aim for cure) or palliative intent (aim for disease control and symptom management). OPSCC is a prominent subset of HNSCCs in Australia and the Western World. Method We looked at the current conventional treatment options with an overview of recent advances and future endeavours. Key findings We identified that radiotherapy is the primary management for OPSCC in most countries, including the USA, UK, NZ, and Australia. In contrast, surgery is only considered for superficial OPSCC or neck surgery. If surgery is incomplete, then definitive management still requires radiotherapy. Conclusion Molecular therapy is largely at the preclinical stage, with cetuximab, nivolumab, pembrolizumab, Lenvatinib, and bevacizumab being tested clinically currently.

show abstract

Transoral robotic surgery advantages and disadvantages: a narrative review

Cited by 3 publications

References 86 publications

Functional Organ Preservation Surgery in Head and Neck Cancer: Transoral Robotic Surgery and Beyond

Functional Organ Preservation Surgery in Head and Neck Cancer: Transoral Robotic Surgery and Beyond

Introduction to Robotics in Skull Base Surgery

Current treatments for oropharyngeal squamous cell carcinoma and the move towards molecular therapy

Contact Info

Product

Resources

About